These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9428918)

  • 1. Mitomycin C and vinorelbine in pretreated breast cancer.
    Colleoni M; Manente P; Stocker J; Amor H; Lamon S; Nelli P; Vicario G; Sgarbossa G; Graiff C
    Tumori; 1997; 83(5):834-6. PubMed ID: 9428918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitomycin "C" and vinorelbine as second line chemotherapy for metastatic breast carcinoma.
    Agostara B; Gebbia V; Testa A; Cusimano MP; Gebbia N; Callari AM
    Tumori; 1994 Feb; 80(1):33-6. PubMed ID: 8191595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
    Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
    Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
    Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin C and vinblastine in combination with amifostine in metastatic breast cancer. A feasibility study of the EORTC--Investigational Drug Branch for Breast Cancer (IDBBC).
    Kusenda Z; Kerger J; Awada A; Geurs F; Van Vreckem A; Habboubi N; Piccart MJ
    Support Care Cancer; 1997 Sep; 5(5):414-6. PubMed ID: 9322355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study.
    De Placido S; Lauria R; Perrone F; Vernaglia Lombardi A; Carlomagno C; Varriale E; Costanzo R; Leo L; De Laurentiis M; Bianco AR
    Oncology; 2000; 58(1):8-14. PubMed ID: 10644934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
    Kornek GV; Haider K; Kwasny W; Hejna M; Raderer M; Meghdadi S; Burger D; Schneeweiss B; Depisch D; Scheithauer W
    Br J Cancer; 1996 Nov; 74(10):1668-73. PubMed ID: 8932353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T; Jagiello-Gruszfeld A
    Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
    Kosmas C; Agelaki S; Giannakakis T; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
    Oncology; 2002; 62(2):103-9. PubMed ID: 11914594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone, fluorouracil plus L-leucovorin, and vinorelbine in pretreated advanced breast cancer.
    Colleoni M; Nelli P; Gaion F; Sgarbossa G; Manente P
    Oncology; 1995; 52(6):435-8. PubMed ID: 7478426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase II trial of two different schedules of mitomycin C and vinorelbine in pretreated breast cancer.
    Colleoni M; Manente P; Stocker J; Amor H; Lamon S; Nelli P; Vicario G; Sgarbossa G; Graiff C
    Oncology; 1997; 54(5):438-9. PubMed ID: 9260607
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
    Pérol M; Guérin JC; Thomas P; Poirier R; Carles P; Robinet G; Kleisbauer JP; Paillotin D; Vergnenègre A; Balmes P; Touron D; Grivaux M; Pham E
    Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin C and vinblastine in anthracycline-resistant metastatic breast cancer: a phase II study.
    Kalofonos HP; Onyenadum A; Kosmas C; Koutras A; Petsas T; Efthimiou V; Koukouras D; Tzoracolefterakis E; Andrikopoulos P; Androulakis J
    Tumori; 2001; 87(6):394-7. PubMed ID: 11989593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal-encapsulated doxorubicin (Myocet; D-99) and vinorelbine in previously treated metastatic breast cancer patients: a feasibility study.
    Poletti P; Bettini AC; Caremoli ER; Labianca R; Tondini C
    Tumori; 2008; 94(5):686-90. PubMed ID: 19112941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients.
    Ospovat I; Siegelmann-Danieli N; Grenader T; Hubert A; Hamburger T; Peretz T
    Tumori; 2009; 95(6):683-6. PubMed ID: 20210229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epirubicin-vinorelbine intravenous combination followed by oral vinorelbine as first-line treatment in metastatic breast cancer.
    Ardizzoia A; Colombo I; Giordano M; Aglione S; Isa L; Scanni A; Scognamiglio G; Bertolini A; Villa F; Gardani G
    Tumori; 2007; 93(6):544-9. PubMed ID: 18338487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment.
    Vassilomanolakis M; Koumakis G; Demiri M; Missitzis J; Barbounis V; Efremidis AP
    Cancer Invest; 2003; 21(4):497-504. PubMed ID: 14533438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic effects of vinorelbine-based chemotherapy--retrospective study of 65 patients with metastatic or relapsed breast cancer].
    Watanabe K; Otake T; Yasuda M; Takenoshita S
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):51-6. PubMed ID: 20087032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.
    Nolè F; Catania C; Sanna G; Imadalou K; Munzone E; Adamoli L; Longerey B; Blanchot G; Goldhirsch A
    Ann Oncol; 2006 Feb; 17(2):322-9. PubMed ID: 16303864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.